IW 365

May 6, 2026 Viktor Zarev 0 min read
  1. CMS to provide $50/mo GLP-1 access for Medicare beneficiaries.
  2. HHS encourages doctors to consider lifestyle changes, not drugs, for depression. 
  3. Pennsylvania sues AI company after chatbot posed as licensed doctor.
  4. Hospitals face growing fallout from ACA coverage cliff.
  5. Judy Faulkner shares keys to Epic’s success in Freakonomics interview.
  6. Are blue zones real? Answering that question is harder than ever.
  7. HCA VP of care transformation steps down.
  8. Eko Health and Boehringer Ingelheim team up to help dogs live longer.
  9. Atrium Health, WakeMed merger faces delay.
  10. Trump’s immigration policies are fueling brain drain.
Get twice-weekly insights on the biggest stories shaping cardiology.

You might also like

Cardiology Pharmaceuticals May 7, 2026

Aficamten, ACACIA-HCM, and the Road to the First nHCM Drug May 7, 2026

The question of how to treat non-obstructive hypertrophic cardiomyopathy has long perplexed researchers and pharmaceutical developers alike, but topline results from Cytokinetics’ Phase 3 ACACIA-HCM trial suggest MYQORZO (aficamten) could be the answer.

Cardiovascular Disease May 4, 2026

The True Cause of Sudden Cardiac Death May 4, 2026

It’s not often that a pair of studies completely challenges our assumptions in cardiology, but new data presented at HRS 2026 suggests myocardial infarction might not be […]

Cardiology April 30, 2026

Cardiac Wire’s Top Six of HRS 2026 April 30, 2026

The Heart Rhythm Society's Annual Meeting for 2026 electrified Chicago with talks of the latest EP tech, rhythm management debates, and insights into where remote patient monitoring is headed. Here are Cardiac Wire’s top-six takeaways from electrophysiology’s biggest weekend of the year.